SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-15-015753
Filing Date
2015-08-13
Accepted
2015-08-13 16:53:44
Documents
1
Period of Report
2015-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3549
  Complete submission text file 0001437749-15-015753.txt   5202
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA GA 30009
Business Address
Azzarello Peter (Reporting) CIK: 0001591980 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 151051362